Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 7 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 11850236

    Method for inhibiting Zika virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted

  2. US 11845778

    Prefusion PIV F immunogens and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted

  3. US 11844769

    Use of cysteamine and derivatives thereof to suppress tumor metastases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted

  4. US 11840561

    Anti-KRAS-G12D T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted

  5. US 11834509

    Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  6. US 11833199

    Peptide fragments from filoviruses and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  7. US 11813316

    Lentiviral vector for treating hemoglobin disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  8. US 11813320

    Genetically engineered foot and mouth disease virus and related proteins, polynucleotides, compositions, methods and systems

    THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF AGRICULTURE · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  9. US 11814440

    Glypican 2 as a cancer marker and therapeutic target

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  10. US 11813319

    Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted

  11. US 11807682

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Heath and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  12. US 11806369

    Exosomes and miRNA to treat glaucoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  13. US 11806406

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted

  14. US 11801296

    Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted

  15. US 11802283

    Oligonucleotide analogues targeting human LMNA

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted

  16. US 11793870

    Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  17. US 11793871

    Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  18. US 11795235

    Immunotoxins with albumin binding domain

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted

  19. US 11786591

    Recombinant metapneumovirus F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  20. US 11787764

    Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  21. US 11786589

    Human rotavirus strains and vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  22. US 11786601

    Pegylated capsule-degrading enzyme for the treatment of anthrax

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Oct 17, 2023 · Expires Oct 12, 2043

    granted

  23. US 11780931

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  24. US 11782065

    Kits and methods for prediction and treatment of preeclampsia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.